Ph.D. Student Profile

Harry  Momo, M.Sc., B.Sc.

Harry Momo, M.Sc., B.Sc.

  • Doctoral Student

Education

MSc. Environmental and Public Health Studies, Kentucky State University, Frankfort, KY (2019)
BSc. Biology and Chemistry, Kentucky State University, Frankfort, KY (2017)

Research Interests & Projects

Throughout my doctoral training, I have developed a strong interest in utilizing observational or epidemiological study methodologies, along with real-world data, to support key aspects of cancer intervention, prevention, and care decision-making. My current dissertation focuses on evaluating the risks and outcomes of various cancers that may be associated with thyroid function. Specifically, my research investigates how conditions such as hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid) or the medications and therapies that treat or induce these conditions, may impact cancer incidence and survival using advanced statistical and methodological approaches such as Mendelian Randomization.

I have had the opportunity to work with several leading research institutions, including the National Cancer Institute (NCI), the University of Michigan Rogel Cancer Center, and the University of Kentucky Markey Cancer Center, among others.

Selected Publications

  • Harry D. Momo, Christian S. Alvarez, Mark P. Purdue, Barry I. Graubard, Katherine A. McGlynn. Associations of per-and polyfluoroalkyl substances and nonalcoholic fatty liver disease in the United States adult population 2003-2018 Environmental Epidemiology 2024 8(1):p e284, doi: 10.1097/EE9.0000000000000284
  • Zin W. Myint, Harry D. Momo, Danielle E. Otto, Donglin Yan, Peng Wang, Jill Kolesar. Evaluation of Fall and Fracture Risk Among Men with Prostate Cancer Treated with Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(11): e2025826.doi:10.1001/jamanetworkopen.2020.25826 
  • Zin W. Myint, Harry D. Momo, Danielle E. Otto, Donglin Yan, Robert S. DiPaola, Peng Wang, Jill Kolesar. “Risk of fall and clinical fracture associated with androgen receptor inhibitors." Journal of Clinical Oncology 38, no 71